• 1
    Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of Mild Hypertension Study: final results. JAMA. 1993;270:713724.
  • 2
    Elmer PJ, Grimm RH, Laing B. Lifestyle intervention: results of the treatment of mild hypertension study (TOMHS). Prev Med. 1995;24:378388.
  • 3
    Wright JT Jr, Harris-Haywood S, Pressel S, et al. Clinical outcomes by race in hypertensive patients with and without metabolic syndrome. Arch Intern Med. 2008;168:207217.
  • 4
    Lithell H, Vessby V. Effect of prazosin on lipoprotein metabolismin premenopausal hypertensive women. J Cardiovasc Pharmacol. 1981;3(Suppl 3):223.
  • 5
    Grimm RH, Flack J, Grandits GA. Long-term effects on plasma lipids of diet and drugs to treat hypertension. JAMA. 1996;275:15491556.
  • 6
    Pool JL, Lenz ML, Taylor AA. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations. J Hum Hypertens. 1990;4(Suppl 3):2333.
  • 7
    ALLHAT Officers and Coordinators for the ALLHAT Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin versus chlorthalidone. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2000;283:19671975.
  • 8
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Diuretic Versus alpha-Blocker as First-line Antihypertensive Therapy: Final Results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension. 2003;42:239246.
  • 9
    Einhorn PT, Davis BR, Cushman WC, et al. The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT) heart failure validation study: diagnosis and prognosis. Am Heart J. 2007;153:4253.
  • 10
    Davis BR, Kostis JB, Simpson LM, et al. Heart failure with preserved and reduced left ventricular ejection fraction in antihypertensive and lipid-lowering treatment to prevent heart attack trial. Circulation. 2008;118(22):225E267E.
  • 11
    Grimm RH, Davis BR, Piller LB, et al. Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome? J Clin Hypertens (Greenwich). 2009;11:466474.
  • 12
    Barzilay JI, Davis BR, Bettencourt J, et al. Cardiovascular outcomes using doxazosin vs chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT Study. J Clin Hypertens. 2004;6(3):116125.